---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-21-000139"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:28:10.799381+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Peptide Technologies names Gregory Pilant CEO/Chairman, Deborah Pilant Secretary/Treasurer

## Summary
- Gregory P. Pilant appointed CEO and Chairman of the Board effective Nov 16, 2021; Deborah L. Pilant appointed Secretary/Treasurer.
- Dennis Cox and Irene Getty resigned from Board of Directors effective Nov 16, 2021.
- Bruce Sellars resigned as CEO but remains on Board; Byron Striloff resigned as President effective Nov 16, 2021.
- Dr. Lee Ori appointed as Chief Operating Officer effective Nov 16, 2021.

## SEC filing metadata
- accession: 0001472375-21-000139
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-21-000139
- JSON: https://secwatch.observer/filing/0001472375-21-000139.json
- Plain text: https://secwatch.observer/filing/0001472375-21-000139.txt

## Key facts
- Executive change
  Dennis Cox resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Deborah L. Pilant was appointed as Secretary/Treasurer at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Secretary/Treasurer
  source text: Effective November 16, 2021, Ms. Deborah L. Pilant has been appointed to serve as Secretary/Treasurer of the Company for the coming year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Bruce Sellars resigned as Chief Executive Officer at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Chief Executive Officer
  source text: Effective November 16, 2021, Bruce Sellars tendered his letter of resignation to the Company resigning from his position as Chief Executive Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Dr. Lee Ori was appointed as Chief Operating Officer at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Chief Operating Officer
  source text: Effective November 16, 2021, Dr. Lee Ori has been appointed to serve as Chief Operating Officer of the Company for the coming year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Gregory P. Pilant was appointed as Chief Executive Officer and Chairman of the Board at REGENEREX PHARMA, INC..
  - Action: appointed
  - Role: Chief Executive Officer and Chairman of the Board
  source text: Effective November 16, 2021, Mr. Gregory P. Pilant has been appointed to serve as Chief Executive Officer and Chairman of the Board for the Company for the coming year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Irene Getty resigned as Member of the Board of Directors at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: Member of the Board of Directors
  source text: Effective November 16, 2021, Dennis Cox and Irene Getty tendered letters of resignation to the Company resigning from their positions as members of the Board of Directors.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm
- Executive change
  Byron Striloff resigned as President at REGENEREX PHARMA, INC..
  - Action: resigned
  - Role: President
  source text: Effective November 16, 2021, Byron Striloff tendered his letter of resignation to the Company resigning from his position as President of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000139/0001472375-21-000139-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.